In last trading session, Protalix BioTherapeutics Inc (AMEX:PLX) saw 1.35 million shares changing hands with its beta currently measuring -0.18. Company’s recent per share price level of $1.67 trading at $0.01 or 0.60% at ring of the bell on the day assigns it a market valuation of $132.95M. That closing price of PLX’s stock is at a discount of -85.63% from its 52-week high price of $3.10 and is indicating a premium of 50.9% from its 52-week low price of $0.82. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.99 million shares which gives us an average trading volume of 920.51K if we extend that period to 3-months.
Protalix BioTherapeutics Inc (AMEX:PLX) trade information
Upright in the green during last session for gaining 0.60%, in the last five days PLX remained trading in the red while hitting it’s week-highest on Thursday, 05/08/25 when the stock touched $1.67 price level, adding 43.0% to its value on the day. Protalix BioTherapeutics Inc’s shares saw a change of -11.17% in year-to-date performance and have moved -41.20% in past 5-day. Protalix BioTherapeutics Inc (AMEX:PLX) showed a performance of -36.26% in past 30-days. Number of shares sold short was 0.74 million shares which calculate 1.02 days to cover the short interests.
Protalix BioTherapeutics Inc (AMEX:PLX)’s Major holders
Insiders are in possession of 13.44% of company’s total shares while institution are holding 5.96 percent of that, with stock having share float percentage of 6.89%. Investors also watch the number of corporate investors in a company very closely, which is 5.96% institutions for Protalix BioTherapeutics Inc that are currently holding shares of the company. MILLENNIUM MANAGEMENT LLC is the top institutional holder at PLX for having 0.81 million shares of worth $0.95 million. And as of 2024-06-30, it was holding 1.1106 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 0.8 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.1016 of outstanding shares, having a total worth of $0.94 million.
On the other hand, Unified Series Trust-AUER GROWTH FUND and Bridgeway Funds, Inc.-Ultra-Small Company Market Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 200.0 shares of worth $0.33 million or 0.25% of the total outstanding shares. The later fund manager was in possession of 180.0 shares on Dec 31, 2024 , making its stake of worth around $0.3 million in the company or a holder of 0.23% of company’s stock.
